Urinary Malondialdehyde as a Biomarker of Type 2 Diabetes Mellitus Treatment in the Primary Care Unit of a Tertiary Care Hospital

Introduction/Objectives The examination of Urinary Malondialdehyde (UMDA) as a biomarker in the involvement of inflammatory response and oxidative stress, as a mechanism underlying the development of diabetes; in addition to complications in followed-up patients at a primary healthcare unit. The lev...

Full description

Bibliographic Details
Main Authors: Thitiworn Choosong, Rattanaporn Chootong, Supinya Sono, Yupa Noofong
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:Journal of Primary Care & Community Health
Online Access:https://doi.org/10.1177/21501327211039987